Topik Spray
Natural health product licensed in Canada
- Licence holder
- Claude Sara
- NPN or DIN-HM
- 80076063
- Status
- Active licence
- Licence date
- 13 March 2017
- Revision date
- 27 June 2018
- Form
- Vaporisateur
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| 2-hydroxybenzoate de méthyle Source : Salicylate de méthyle | 10 Pour cent |
| Huile Essentielle d'Eucalyptus Source : Feuille | 1 Pour cent |
| l-Menthol Source : l-Menthol | 2.5 Pour cent |
| d-camphre Source : d-Camphre | 3 Pour cent |
| Syzygium aromaticum Source : Bourgeon floral | 0.5 Pour cent |
Non-medicinal ingredients
Eau purifiée, Huile essentielle de cannelle, Huile essentielle de gingembre, Isopropanol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | 1 Pulvérisateur | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms worsen after 7 days or re-occur within a few days, discontinue use and consult a health care practitioner. If you are pregnant or breastfeeding, consult a healthcare practitioner prior to use. If you are taking anticoagulant medications, consult a health care practitioner prior to use.
- Effets indésirables connus
Rashes and/or burning discomfort have been known to occur; in which case, discontinue use. Hypersensitivity has been known to occur; in which case, discontinue use. If you experience pain, swelling or blistering, stop use and get medical help right away.
Source
Official Health Canada record, licence 80076063
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging